A questionnaire to measure morbidity in patients receiving radiation therapy for head and neck cancer
Peter Skingley, C. Cripps(Canadian Partnership Against Cancer), Mark Levine(Lancaster University), I. Hodson, R Russell, George P. Browman(Hamilton Regional Laboratory Medicine Program)
Cited by 0
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy
|Journal of Clinical Oncology|2016|291
Phase III Trial of Fluorouracil-Based Chemotherapy Regimens Plus Radiotherapy in Postoperative Adjuvant Rectal Cancer: GI INT 0144
|Journal of Clinical Oncology|2006|167
The Head and Neck Radiotherapy Questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer.
|Journal of Clinical Oncology|1993|161
Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer.
|Journal of Clinical Oncology|1994|139